Joseph G. Pressey · Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.
Follow
Article1 min read·Published Nov 2026

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Nov 2026 · 1 min read

In brief

In brief

This case report describes a rare presentation of small cell carcinoma of the ovary hypercalcemic type (SCCOHT) in a patient with dual germline mutations in both SMARCA4 and BRCA2. The authors detail the clinical presentation, pathology findings, and multimodal treatment approach including systemic chemotherapy and hyperthermic intraperitoneal chemotherapy for this aggressive malignancy.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is a rare and aggressive disease. While classically linked to mutations in SMARCA4, we describe a case in a patient with both SMARCA4 and BRCA2 germline mutations. We describe her disease presentation, histopathology and treatment with adjuvant systemic chemotherapy, interval hyperthermic intraperitoneal chemotherapy, high dose chemothe…

Statements in this article

  1. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is a rare and aggressive disease.

    Established
  2. SCCOHT is classically linked to mutations in SMARCA4.

    Established
  3. A case of SCCOHT has been identified in a patient with both SMARCA4 and BRCA2 germline mutations.

    Research
  4. Treatment approaches for SCCOHT include adjuvant systemic chemotherapy, interval hyperthermic intraperitoneal chemotherapy, and high-dose chemotherapy.

    Research

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.